Obesity
RecruitingZenagamtide for Weight Loss in Adults with Obesity
Zenagamtide for Weight Loss in Adults with Obesity
- Disease:Obesity
- Substances:–
France- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Zenagamtide for Weight Loss in Adults with Obesity
FranceLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
FranceBelzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
France[18F]CPFPX PET in Patients With Drug-Resistant Epilepsy and Healthy Subjects
FranceAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
FranceFrexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients
FranceTreatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia
FranceA study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease
FranceA study of belzutifan and lenvatinib for patients with von Hippel-Lindau disease-associated tumors or other specific solid tumors.
FranceA study to evaluate the efficacy and safety of DYNE-101 in patients with Myotonic Dystrophy Type 1
France
FranceEvaluating the use of capecitabine, oxaliplatin, fluorouracil, folinic acid, and irinotecan to personalize chemotherapy for patients with stage III colorectal cancer
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.